BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 33641310)

  • 21. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.
    Toki S; Goleniewska K; Reiss S; Zhou W; Newcomb DC; Bloodworth MH; Stier MT; Boyd KL; Polosukhin VV; Subramaniam S; Peebles RS
    Thorax; 2016 Jul; 71(7):633-45. PubMed ID: 27071418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in group 2 innate lymphoid cell-dominant allergic airway inflammation.
    Wang C; Xu ZB; Peng YQ; Zhang HY; Yu QN; Guo YB; Tan WP; Liu YL; Meng XC; Fang SB; Chen D; Fu QL
    Mol Immunol; 2020 Dec; 128():89-97. PubMed ID: 33096416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate Lymphoid Cells in Airway Inflammation.
    Asghar Pasha M; Yang Q
    Adv Exp Med Biol; 2021; 1303():183-191. PubMed ID: 33788194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis.
    Mohapatra A; Van Dyken SJ; Schneider C; Nussbaum JC; Liang HE; Locksley RM
    Mucosal Immunol; 2016 Jan; 9(1):275-86. PubMed ID: 26129648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
    Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
    J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cells are the critical source of IL-4/IL-13 in a mouse model of allergic asthma.
    Oeser K; Maxeiner J; Symowski C; Stassen M; Voehringer D
    Allergy; 2015 Nov; 70(11):1440-9. PubMed ID: 26214396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.
    Christianson CA; Goplen NP; Zafar I; Irvin C; Good JT; Rollins DR; Gorentla B; Liu W; Gorska MM; Chu H; Martin RJ; Alam R
    J Allergy Clin Immunol; 2015 Jul; 136(1):59-68.e14. PubMed ID: 25617223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
    Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
    J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.
    Wallrapp A; Riesenfeld SJ; Burkett PR; Abdulnour RE; Nyman J; Dionne D; Hofree M; Cuoco MS; Rodman C; Farouq D; Haas BJ; Tickle TL; Trombetta JJ; Baral P; Klose CSN; Mahlakõiv T; Artis D; Rozenblatt-Rosen O; Chiu IM; Levy BD; Kowalczyk MS; Regev A; Kuchroo VK
    Nature; 2017 Sep; 549(7672):351-356. PubMed ID: 28902842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-γ Blocks Development of an Asthma Phenotype in Rhinovirus-Infected Baby Mice by Inhibiting Type 2 Innate Lymphoid Cells.
    Han M; Hong JY; Jaipalli S; Rajput C; Lei J; Hinde JL; Chen Q; Hershenson NM; Bentley JK; Hershenson MB
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):242-251. PubMed ID: 27679954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Involvement of Type 2 Innate Lymphoid Cells in Airway Inflammation of Asthma.
    Shi R; Bian X; Feng S; Yang X; Zhao T; Guo M
    J Interferon Cytokine Res; 2020 Apr; 40(4):188-194. PubMed ID: 32150691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are ILC2s Jekyll and Hyde in airway inflammation?
    Ealey KN; Moro K; Koyasu S
    Immunol Rev; 2017 Jul; 278(1):207-218. PubMed ID: 28658554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group 2 innate lymphoid cells and asthma.
    Kabata H; Moro K; Koyasu S; Asano K
    Allergol Int; 2015 Jul; 64(3):227-34. PubMed ID: 26117253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of group 2 innate lymphoid cells (ILC2) in respiratory allergic diseases: An update].
    Luo C; Liu S; Ren Q; Peng S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):552-557. PubMed ID: 37340924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
    Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
    Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
    [No Abstract]   [Full Text] [Related]  

  • 39. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
    Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
    J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
    Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.